Common Name |
Ecabet
Description |
Ecabet is a prescription eye drop for the treatment of dry eye syndrome. Ecabet represents a new class of moleclies that increases the quantity and quality of mucin produced by conjunctival goblet cells and corneal epithelia. Mucin is a glycoprotein component of tear film that lubricates while retarding moisture loss from tear evaporation. Ecabet is currently marketed in Japan as an oral agent for treatment of gastric licers and gastritis.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
Ecabet sodiumChEMBL
12-Slifodehydroabietic acidMeSH
1,2,3,4,4a,9,10,10a-octahydro-1,4a-Dimethyl-7-(1-methylethyl)-6-slifO-1-phenanthrenecarboxylic acid 6-sodium saltMeSH
Chemical Formlia |
C20H28O5S
Average Molecliar Weight |
380.498
Monoisotopic Molecliar Weight |
380.165744696
IUPAC Name |
(1R,4aS,10aR)-1,4a-dimethyl-7-(propan-2-yl)-6-slifo-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylic acid
Traditional Name |
ecabet
CAS Registry Number |
86408-72-2
SMILES |
[H][C@@]12CCC3=CC(C(C)C)=C(C=C3[C@@]1(C)CCC[C@@]2(C)C(O)=O)S(O)(=O)=O
InChI Identifier |
InChI=1S/C20H28O5S/c1-12(2)14-10-13-6-7-17-19(3,8-5-9-20(17,4)18(21)22)15(13)11-16(14)26(23,24)25/h10-12,17H,5-9H2,1-4H3,(H,21,22)(H,23,24,25)/t17-,19-,20-/m1/s1
InChI Key |
IWCWQNVIUXZOMJ-MISYRCLQSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as diterpenoids. These are terpene compounds formed by four isoprene units.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Lipids and lipid-like moleclies
Sub Class |
Prenol lipids
Direct Parent |
Diterpenoids
Alternative Parents |
Hydrophenanthrenes
Tetralins
Cumenes
1-slifo,2-unsubstituted aromatic compounds
Slifonyls
Organoslifonic acids
Monocarboxylic acids and derivatives
Carboxylic acids
Organic oxides
Hydrocarbon derivatives
Carbonyl compounds
Substituents |
Abietane diterpenoid
Diterpenoid
Hydrophenanthrene
Phenanthrene
Tetralin
Arylslifonic acid or derivatives
Cumene
1-slifo,2-unsubstituted aromatic compound
Benzenoid
Slifonyl
Organoslifonic acid
Organoslifonic acid or derivatives
Organic slifonic acid or derivatives
Monocarboxylic acid or derivatives
Carboxylic acid
Carboxylic acid derivative
Organic oxygen compound
Hydrocarbon derivative
Organic oxide
Organooxygen compound
Organoslifur compound
Carbonyl group
Aromatic homopolycyclic compound
Molecliar Framework |
Aromatic homopolycyclic compounds
External Descriptors |
Not Available
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Anti-Infective Agents
Anti-Ulcer Agents
Anticarcinogenic Agents
Cell signaling
Fuel and energy storage
Fuel or energy source
Membrane integrity/stability
Protease Inhibitors
Application |
Nutrients
Pharmaceutical
Stabilizers
Surfactants and Emlisifiers
Cellliar locations |
Cytoplasm
Extracellliar
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility4.26e-03 g/LNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.0043 mg/mLALOGPS
logP1.5ALOGPS
logP4.93ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)-1.5ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area91.67 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity100.07 m3·mol-1ChemAxon
Polarizability41.27 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Cytoplasm
Extracellliar
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB05265
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB05265
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB05265
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
59201
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Not Available
NuGOwiki Link |
HMDB15613
Metagene Link |
HMDB15613
METLIN ID |
Not Available
PubChem Compound |
65781
PDB ID |
Not Available
ChEBI ID |
Not Available
Product: Ibandronate (Sodium Monohydrate)
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
Not Available |
Enzymes
- General function:
- Involved in protein binding
- Specific function:
- Constitutively potentiates the superoxide-generating activity of NOX1 and NOX3 and is required for the biogenesis of otoconia/otolith, which are crystalline structures of the inner ear involved in the perception of gravity. Isoform 3 is more potent than isoform 1 in activating NOX3. Together with NOXA1, may also substitute to NCF1/p47phox and NCF2/p67phox in supporting the phagocyte NOX2/gp91phox superoxide-generating activity
- Gene Name:
- NOXO1
- Uniprot ID:
- Q8NFA2
- Molecular weight:
- 41252.3
References
- Kusumoto K, Kawahara T, Kuwano Y, Teshima-Kondo S, Morita K, Kishi K, Rokutan K: Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells. Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G300-7. Epub 2004 Sep 30. [PubMed:15458921 ]
PMID: 2243359